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A B S T R A C T
Prisons are associates as facilities liable of high risk of infection disease, as a result of the possibility of transmission
of infections in prisons surroundings. Investigations carried out in correctional facilities around the world have shown a
high prevalence of blood borne hepatitis viruses and HIV. The study was aimed at confirming prevalence of HIV, hepatitis
B and hepatitis C among prisoners in Bitola’s, and Prilep’s prisons, existing of co-infection as well to assess knowledge
and attitudes related to HIV, HBV and HCV infections. In this cross-sectional study 200 prisoners have participated, pro-
viding answers to structured questionnaire and in order to analyze blood for HIV, HBV and HCV, rapid blood tests in de-
tecting antibodies has been used. Prevalence of HCV is 0.20, HBV 0.17 and HIV prevalence is 0. Co-infection prevalence
of HCV/HBV is 0.07 from the total number of examinees. As for the manner of infection with HIV virus 22% are familiar
with the fact that persons cannot be infected by HIV if they have only one sexual partner who is not infected and have no
other partners, and for the protection of HIV and Hepatitis B by correct use of condoms-58% have given correct answers.
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Introduction
Prisons are known for connection of high risk of infec-
tion diseases1,2 as a result of possibility of transmission of
infections in prisons surroundings3,4. Persons with infe-
rior health status are main representatives among those
who have contact with criminal juristic system5.
Investigations carried out in correctional facilities
around the world have shown a high prevalence of blood
borne hepatitis viruses and HIV6–8. Among high-risk en-
vironments, prisons are well-known establishments for
spreading of blood-borne viruses. Those who use illicit
drugs or engage in sex work are often incarcerated. In
addition, during imprisonment, prisoners often engage
in unprotected sex, syringe/needle sharing, or sharing of
other paraphernalia (spoon, water) because of the lim-
ited access to condoms and injecting equipment, etc.9,
tattooing and scarification are also common10.
Low education level may act as one of the factors that
cause lack of knowledge about HIV/AIDS in prison popu-
lation. It may become one of shortcomings in preventing
and solving the problem of HIV/AIDS. People need to
know about what HIV/AIDS is, its symptoms, mode of
HIV/AIDS transmission, risk factors, preventions, and
what they must do if they have suspected symptoms of
HIV/AIDS; therefore, people can participate to help the
government programs of solving HIV/AIDS problems.
The prison establishments are rather convenient for
spreading of diseases and therefore there is a solid oppor-
tunity for further studying and intervention of such dis-
eases.11 Because of that, a better knowledge of the preva-
lence rates of these infections in prisons would help
better preventive measures undertaking of better plan-
ning12,13 The main goal of the study was to assess the
prevalence and risk factors of HIV, HBV, Hepatitis B and
C, and HCV among incarcerated men in Prilep and
Bitola, and as additional goal was to assess the knowl-
edge and attitudes related to HIV, HBV and HCV infec-
417
Received for publication July 5, 2013
tion. The hypothesis introduced in the study: Prevalence
of HIV, HBV and HCV infection in inmates population is
higher than prevalence in general population, and there
is a statistical significant difference that exists compared
to prevalence of HIV, HBV, HCV infection depending of
exposition to risk factors.
Material and Methods
A cross-sectional PILOT study about the prevalence
and risk factors for occurring HIV, HBV and HCV infec-
tion was conducted among inmates. The research was
performed in two correctional institutions in the Repub-
lic of Macedonia, in Bitola and Prilep for the period be-
tween September and December 2011. The study sample
consisted of 200 examinees in total, 100 from Bitola’s
prison (with a capacity of 100 prisoners) and 100 from
Prilep’s prison (with a capacity of 100 prisoners).
Criteria for including in the research were: age (18
and above) with a minimum stay of 3 months in correc-
tional facility. Criteria for excluding were age (less than
18), time at stay less than 3 months, illiteracy and men-
tal ineligibility.
A core questionnaire was the instrument for the re-
search, composed on the basis of similar researches. As
medical diagnostic tool were used certain rapid tests for
detection HIV, hepatitis B and hepatitis C infections as
well. All participants signed an informed consent and
provided a blood sample.
The questionnaire is composed of two segments. The
first segment comprised data referring general demo-
graphic characteristics and socio-economic status (11
questions), second segment comprised of questions refer-
ring to habits, risk sexual behaviors and intravenous
drug use and knowledge and attitudes related to HIV,
HBV and HCV infection (20 questions).
As a medical diagnostic tool were used rapid detecting
tests for HCV, HBV and HIV. Hexagon HCV is intended
for rapid, qualitative detection of IgG antibodies to the
hepatitis C virus in human serum plasma or whole blood.
The onsite HIV1/2 Ab plus Combo rapid test is a lateral
flow immunoassay for the simultaneous detection and
differentiation of anti-HIV1 and anti-HIV2 antibodies in
human serum plasma or whole blood. On site HBV5 Pa-
rameter rapid test is chromatographic test for qualitative
detection of HbsAg, HbsAb, HbeAb, HbeAg and HbcAb
in human serum or plasma.
The questionnaire was anonymous and the participa-
tion was voluntarily in accordance to previous written
approval by the Ethical Committee and Executive Sanc-
tion Board of the Ministry of Justice in the Former Yugo-
slav Republic of Macedonia.
For statistical analysis and analysis of received data
were used the following adequate statistic methods: Co-
efficient relation, proportion, rata of statistic series with
attributive features. Dispersion measures (standard de-
viation, standard error) were used as for the analysis of
data of numerical features. Statistic significant differ-
ence at series with attributive and numerical features
was detected after testing of given hypothesis, using ade-
quate statistic test- Pearson chi-square test. Odds ratio is
also calculated and Confidence Interval for un-separate
variables. Statistic significant is made for p<0.05. The
study is performed by statistical program SPSS version
14.
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TABLE 1
PREVALENCE OF HCV, HBV AND HIV IN PRISONS PRILEP AND
BITOLA AND EXISTENCE OF CO INFECTION (HCV/HBV) N=200
Types of viral infection N % Prevalence
HCV+ 40 20% 0.20
HBV+ 34 17% 0.17
HIV+ 0 0% 0.00
HCV/HBV co-infection 14 7% 0.07
TABLE 2
ASSOCIATION BETWEEN RISKY BEHAVIOUR AND HCV+
Risky behaviour ÷2 p OR 95% CI
i.v. drug using 9.117 0.0278 2.9139 1.4311–5.9328
Place of taking out or in prison 10.375 0.0156 3.1235 1.5321–6.3652
Joint equipment 4.800 0.4408
Tatooing 5.0511 0.0244
Sterile needle for tatooing 4.205 0.7559
Sexual contact (vaginal and anal) 3.898 0.0484
Constant partner 0.838 0.8405
Sexual contact 6.590 0.0862
Sexual contact with same sex 0.016 0.9995
Sexual contact with drug user 10.197 0.0698 0.1644 0.0417–0.6484
Condom with constat partner 10.871 0.4542
Condom with non constat partner 8.0204 0.3886
Results
Within the investigated group of 200 prisoners, 100
examinees (50.0%) from Prilep’s prison and 100 (50.0%)
from Bitola’s prison, the testing was done with rapid de-
tection tests of HCV, HBV and HIV and filling up the
questionnaires as well. Average age of all prisoners is
29.69 years with SD±7.65 (min. 19, max. 54). From total
number of 200 examines, 13 (6.5%) are without educa-
tion, 40 (20%) with incomplete education, 65 (32.5%)
with elementary education, 73 (36.5%) secondary educa-
tion (3 or 4 years), 3 (1.5%) college and 6 (3%) high
school. The highest percentage 91 (45.5%) of the inmates
are condemned for heist, 39 (19.5%) for drug abuse, 20
(10%) for robbery, 9 (4.5%) for murder and the least
number 5 (2.5%) are condemned for traffic threatening,
and 36 (18%) regarding other criminal acts. As for the
marital status, 64 (32%) married, 108 (54%) single, 28
(14%) illegitimate community 87% live in towns and 13%
in villages.
Table 1 presents the prevalence of HCV, HBV and HIV
among prisoners in both prisons in the Former Yugoslav
Republic of Macedonia.
From 200 inmates 40 (20%) are HCV positive while
160 (80%) HCV negative, 34 (17%) are HBV positive
while 166 (83%) are HBV negative. None of the 200 in-
mates is HIV positive. Total prevalence of HCV is 0.20,
total prevalence of HBV is 0.17. Prevalence of co-infec-
tion of HCV/ HBV is 0.07 (7%) from 200 examinees.
Table 2 depicts connection between risky behavior
and HCV positive status. The statistical significant con-
nection among examinees is being registered between
HCV positive status of incarcerated and intravenous
drug use, place of taking drug – out or in prison, tattoo-
ing, sexual intercourse/vaginal and anal, sexual contact,
sexual intercourse with intravenous drug user for p<
0.05.
According to cross-sectional relation, intravenous drug
using is a risk factor for infection with HCV–OR=2.9139
(95% Confidence Interval from1.4311 to 5.9328) place of
taking drug is a risk factor for HCV infection – Odds Ra-
tio=3.1235 (95% Confidence Interval from 1.5327 tî
6.3652). Value for Odds Ratio is 0,1644 (95% Confidence
Interval from 0.0417 to 0.6484) between correlation of
sexual intercourse with intravenous drug andHCV status.
Table 3 presents connection between risky behavior
and HBV positive. Statistical signification is registered
between HBV status of prisoners and sexual intercour-
se/vaginal and anal (÷2=0.2204; df=1; p=0.0359).
Table 4 presents the statements of examinees related
to attitudes and knowledge about HIV, HBV and HCV. As
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TABLE 3
ASSOCIATION BETWEEN RISKY BEHAVIOUR AND HBV+
Risky behaviour ÷2 p
i.v. drug using 0.128 0.9883
Place of taking out or in prison 1.507 0.6805
Joint equipment 2.891 0.7168
Tatooing 1.4403 0.5118
Sterile needle for tatooing 4.476 0.4831
Sexual contact (vaginal and anal) 0.2204 0.0359
Constant partner 0.506 0.9175
Sexual contact 0.8913 0.3457
Sexual contact with same sex 0.131 0.9879
Sexual contact with drug user 1.353 0.9294
Condom with constat partner 9.182 0.6051
Condom with non constat partner 0.362 1.0000
TABLE 4








Persons can be infected by HIV if they have only one sexual partner who
is not infected and have no others.
43–22% 81–42% 70–36%
Persons can be protected by HIV and HBV infection with correct use
of condom
113–58% 27–14% 54–28%
Person who seems healthy may be infected by HIV 112–58% 12–6% 70–36%
Pearson can be infected by HIV, hepatitis B and C if has meals together
with someone who is infected
37–19% 57–29% 100–52%
Pearson can be infected by HIV if lives or works together with someone
who is infected with HIV
52–27% 65–34% 77–40%
Prisoner who is positive to Hepatitis B or C should be isolated 38–20% 60–31% 96–49%
HIV, Hepatitis B and C trannsmited by using contaminated syringes and
needle
47–24% 58–30% 89–46%
Testing to HIV, Hepatitis B and C is needed to all persons condemned to
prison immediatly after entering
110–57% 18–9% 66–34%
Prisoner who is infected with HIV should not be allowed contact with
other prisoners.
82–42% 35–18% 77–40%
for the manner of infection with HIV virus 22% are fa-
miliar with the fact that persons can’t be infected by HIV
if they have only one sexual partner (uninfected and
without other partners), 42% gave wrong answer, and
36% are not familiar at all. For the protection of HIV and
Hepatitis B by correct use of condoms–58% have given
correct answers. 14% wrong, 28% are not familiar. 58%
answered correctly that person may be HIV and Hepati-
tis B infected even though that person appears as healthy
and only 29% give correct answer to the question „Per-
son can be infected by HIV, hepatitis B and C if sharing
meals together with someone who is infected. Only 42%
have discriminatory attitude about people infected by
HIV (»A prisoner infected with HIV should not be al-
lowed to contact with other prisoners«), and around 40%
have no attitude about this matter. 20% have prejudices
about people who are positive to HCV and HBV (»A pris-
oner positive in Hepatitis B or C should be isolated«).
According to the statement »HIV, Hepatitis B and C
trannsmited by using contaminated syringes and needle«
correct answer was given in 24%, 30% have given wrong
answer, a 46% were not familiar.
Connection between statements of examinees related
to attitudes and knowledge about viral infections and
HCV and HBV status is shown in table 5 and 6. As of the
low values of Pearson Chi square and p>0.05, between
statement HCV and HBV status of examinees does not
exist statistical signification.
Discussion
This pilot research is conducted in two correctional
facilitates in the Former Yugoslav Republic of Macedonia
(Prison in Prilep and Bitola) indicates significant higher
prevalence of HCV and HBV infections at prisoners re-
ferring to general population. In the Former Yugoslav
Republic of Macedonia is that 1.5% of the general popula-
tion are infected or around 30.000 are HCV positive
cases. Up to recent knowledge, 5 to 7% of the population
is infected with hepatitis B virus, and the last year 166
cases of HIV-AIDS are registered, only this year 20 new
cases.
Data obtained by the research comprising 200 exa-
minees being condemned to prison using rapid detection
tests for HCV, HBV and HIV indicated relatively high
prevalence of hepatitis B and hepatitis C. Prevalence of
HCV is 0.20 (20.0%), HBV 0.17 (17.0%) and HIV preva-
lence is 0 (0%). Co-infection prevalence of HCV/HBV is
0.19 from positive examinees.
Researches that have been done in prison institutions
in neighbor countries and the surrounding areas which
indicated similar results. In Bulgaria national report re-
ferring to 2008 shows high percentage of HCV (13.5%)
and HBV (11.8%) in prisoners – due to illegal using drugs
and high certainty of tattooing14. A cross-sectional study
was done in Hungary’s prisons. The rata of HCV was sig-
nificantly higher among intravenous drug users (22.5%)15.
Prevalence of HCV in Croatia prisons is 12.5% and com-
paring to general population is significantly higher16.
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TABLE 5














Persons can be infected by HIV if they have
only one sexual partner who is not infected
and have no others.
8 35 21 60 2.529 0.7721
Persons can be protected by HIV and HBV
infection with correct use of condom
25 88 5 22 0.374 0.9960
Person who seems healthy may be infected
by HIV
21 91 4 8 3.2338 0.6722
Pearson can be infected by HIV, hepatitis B
and C if has meals together with someone
who is infected
6 31 11 46 0.845 0.9741
Pearson can be infected by HIV if lives or
works together with someone who is
infected with HIV
8 44 18 47 3.139 0.6786
Prisoner who is positive to Hepatitis B or C
should be isolated
6 32 17 43 3.223 0.6657
HIV, HepatitisB and C trannsmited by
using contaminated syringes and needle
12 35 11 47 0.916 0.9691
Testing to HIV, Hepatitis B and C is needed
to all persons condemned to prison
immediatly after entering
24 86 5 13 1.292 0.9357
Prisoner who is infected with HIV should
not be allowed contact with other prisoners
16 66 10 25 1.961 0.8901
Accessible global data indicate high prevalence and
transmission of infectious diseases such as TBC, HIV,
syphilis, Hepatitis B virus (HBV), Hepatitis C virus (HCV)
in prisons 17,18 Prevalence of HIV, HBV and HCV-a, is reg-
istries among 357 randomly chosen prisoners in male
prisons in Karachi-Pakistan and is 2.0%, 5.9% i 15.2% 19.
At examinees in prisons in the Former Yugoslav Re-
public of Macedonia statistically significant association is
registered between risky behaviors and positive status
and intravenous drug use, intercourse with intravenous
drug user for p<0.05. Studies show that also in Estonian
prisons the existing risky factors are; injecting of drugs,
using join equipment and unprotected sexual contacts.
Almost one third of interviewed prisoners have reported
drug injecting in prison, two thirds reported using of
joint equipment and less than 10% drug users started
with it in prison20.
As for the existence of HIV virus, HBV and HCV high
percentage of prison population in Macedonian prisons
(94%) is well-informed. Similar results about attitudes
and knowledge for HIV and other sexually transmitted
diseases obtained also in study in Republic of Serbia21,
and in Croatia where study was conducted for risk be-
havior in getting HIV at MSM. Almost all (99.3%) of the
respondents are familiar about HIV/AIDS22.
Recent study investigated knowledge, attitudes and
habits for prevention of HIV among samples of Iranian
incarcerated23. Prisoners in Mazandran province have
shown average level of knowledge on HIV. But there were
wrong understandings as well (34.8% out of 1760 prison-
ers) assumed that HIV/AIDS is not an infectious disease.
Numerous countries in the world nowadays show sig-
nificant percentage of drug addicts people entering the
prison and the majority of them continue injecting drugs
after entering24.
Comparing to general not incarcerated population,
prisoners worldwide continue showing significantly
higher prevalence of HIV, HBV and HCV infections25.
Identification of risk factors and risk behavior in prison-
ers and determination of stigmatization and discrimina-
tion level indicates undertaking preventive measures in
due time26.
Study conducted in Serbia showed that sexual work-
ers had a very poor knowledge of HIV transmission27.
Conclusion
As of the confirmed knowledge of prisons conditions
and conducted study of the prevalence of HCV, HBV and
HIV infections suggest the necessity of well organized
health service-especially, immunization programs, infec-
tious disease screening, treatment, and promotion of liv-
ing conditions in prisons.
Ethical approval
The research was conducted by anonymous question-
naires in accordance to the approval of each interviewed
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TABLE 6














Persons can be infected by HIV if they have
only one sexual partner who is not infected
and have no others.
4 39 18 63 2.4731 0.6681
Persons can be protected by HIV and HBV
infection with correct use of condom
15 98 7 20 3.558 0.6146
Person who seems healthy may be infected
by HIV
16 96 4 8 3.193 0.6702
Pearson can be infected by HIV, hepatitis B
and C if has meals together with someone
who is infected
3 34 12 45 2.906 0.7145
Pearson can be infected by HIV if lives
or works together with someone who is
infected with HIV
5 47 15 50 3.659 0.5995
Prisoner who is positive to Hepatitis B or C
should be isolated
5 33 12 48 0.756 0.9797
HIV, HepatitisB and C trannsmited by
using contaminated syringes and needle
8 39 8 50 1.013 0.9615
Testing to HIV, Hepatitis B and C is needed
to all persons condemned to prison
immediatly after entering
20 90 4 14 0.569 0.9894
Prisoner who is infected with HIV should
not be allowed contact with other prisoners
17 65 5 35 1.046 0.9596
person and the Ethics Committee of the Medical Faculty
at the University of Skopje, approval by the Ministry of
Justice, particularly by the Directory of execution of
sanctions – governing with prisons.
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PREVALENCIJA, STAVOVI I ZNANJA O HIV, HBV I HCV INFEKCIJA ME\U ZATVORENICIMA
U ZATVORIMA PRILEPU I BITOLI – PILOT STUDIJA
S A @ E T A K
Zatvori se poistovje}uju sa postrojenjima podlo`nim visokom stopom rizika infekcija, kao rezultat mogu}nosti pri-
jenosa infencija u zatvorskom okru`enju. Istra`ivanja provedena u popravnim ustanovama diljem svijeta pokazala su
visoku u~estalost virusa hepatitisa i HIV-a putem krvi. Istra`ivanje je usmjereno prema potvr|ivanju prevalencije
HIV-a, hepatitisa B i hepatitisa C me|u zatvorenicima zatvora u Bitoli i Prilepu i postojanju koinfekcije, kao i prema
procjeni znanja i stavova vezanih uz HIV, HBV i HCV infekcije. U ovoj cross-sectional studiji sudjelovalo je 200 zatvo-
renika, pru`aju}i odgovore na strukturirane upitnike, dok su za analizu krvi kori{teni brzi krvni testovi u detekciji
antitijela. Prevalencija HCV iznosi 0,20, HBV-a 0,17 i HIV-a 0. Koinfekcijska prevalencija HCV/HBV-a iznosi 0,07 od
ukupnog broja ispitanika. 22% ispitanika je upoznato sa ~injenicom kako ne mogu biti zara`eni HIV-om ako imaju samo
jednog seksualnog partnera koji nije zara`en, dok je njih 58% dalo to~ne odgovore za za{titu od HIV-a i hepatitisa B
ispravnim kori{tenjem kondoma.
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